P15121 (ALDR_HUMAN) Homo sapiens (Human)

Aldo-keto reductase family 1 member B1 UniProtKBInterProSTRINGInteractive Modelling

316 aa; Sequence (Fasta)

Available Structures

173 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
FIDARESTAT BOUND TO HUMAN ALDOSE REDUCTASE
1ef3
homo-2-mer2-316
2×NAP; 2×FID;
Assess
Crystal structure of human AR complexed with NADP+ and {2-[(4-bromo-2,6-difluorobenzyl)carbamoyl]-5…
4lbs
monomer1-316
1×NAP; 1×4O8;
Assess
Crystal structure of Aldose Reductase complexed with 2S4R (Stereoisomer of Fidarestat, 2S4S) at 0.7…
3bcj
monomer1-316
1×NAP; 1×CIT; 1×FIS;
Assess
Crystal structure of human AR complexed with NADP+ and {2-[(4-bromo-2,3,5,6-tetrafluorobenzyl)carba…
4lb4
monomer1-316
1×NAP; 1×1WX;
Assess
Crystal structure of human AR complexed with NADP+ and {5-chloro-2-[(2-fluoro-4-iodobenzyl)carbamoy…
4lb3
monomer1-316
1×NAP; 1×M15;
Assess
Crystal structure of human AR complexed with NADP+ and {5-chloro-2-[(2,6-difluoro-4-iodobenzyl)carb…
4lbr
monomer1-316
1×NAP; 1×4O9;
Assess
Human aldose reductase in complex with NADP and citrate at 0.82 angstrom
2j8t
monomer1-316
1×NAP; 2×FLC;
Assess
Crystal structure of human AR complexed with NADP+ and {2-[(4-bromobenzyl)carbamoyl]-5-chlorophenox…
4lau
monomer1-316
1×NAP; 1×W8X;
Assess
Crystal structure of human Aldose Reductase complexed with NADP+ and JF0064
4igs
monomer1-316
1×NAP; 1×64I;
Assess
Crystal structure of human AR complexed with NADP+ and {5-chloro-2-[(4-iodobenzyl)carbamoyl]phenoxy…
4laz
monomer1-316
1×NAP; 1×1WW;
Assess
Complex of Aldose Reductase with NADP+ and simaltaneously bound competetive inhibitors Fidarestat a…
2pf8
monomer1-316
1×CL; 1×NDP; 1×LDT; 1×FID; 2×CIT;
Assess
Complex of Aldose Reductase with NADP+ and simaltaneously bound competetive inhibitors Fidarestat a…
2pev
monomer1-316
1×CL; 1×NDP; 1×LDT; 1×FID; 1×CIT;
Assess
Crystal structure of human Aldose Reductase complexed with NADP and Fidarestat
1pwm
monomer1-316
1×CL; 1×NAP; 1×FID;
Assess
AKR1B1 at 0.03 MGy radiation dose.
6f7r
monomer1-316
1×NAP; 2×CIT;
Assess
human Aldose Reductase in complex with SAR25
6syw
monomer1-316
1×NAP; 1×CIT; 1×M0K;
Assess
Structure of Human Aldose Reductase Mutant L300G with a Citrate Molecule Bound in the Anion Binding…
8a4n
monomer1-316
1×NAP; 2×CIT;
Assess
Crystal structure of human AKR1B1 complexed with NADP+ and compound 37
5ou0
monomer1-316
1×NAP; 1×AV5;
Assess
Human Aldose Reductase Mutant L300/301A in Complex with a Ligand with an IDD Structure (3-({[2-(car…
6y1p
monomer1-316
2×4G7; 1×CIT; 1×NAP;
Assess
Human Aldose Reductase mutant T113V complexed with IDD388
3m4h
monomer1-316
1×NAP; 1×388; 1×CIT; 1×BR;
Assess
Human Aldose Reductase Mutant L300G in Complex with a Ligand with an IDD Structure (3-({[2-(carboxy…
8cnp
monomer1-316
1×NAP; 1×4G7; 1×CIT;
Assess
Human Aldose Reductase in Complex with a Hydroxyphenyl-Thiophen-Acid Inhibitor (Schl32357)
8ae9
monomer1-316
1×NAP; 1×LZO; 1×DMS;
Assess
Human Aldose Reductase Mutant A299G in Complex with a Ligand with an IDD Structure ({5-fluoro-2-[(3…
8auu
monomer1-316
1×NAP; 1×30L; 1×CIT;
Assess
Human Aldose Reductase Mutant A299G in Complex with a Ligand with an IDD Structure (3-({[2-(carboxy…
8b66
monomer1-316
1×NAP; 1×CIT; 1×4G7;
Assess
Human Aldose Reductase Mutant L300A in Complex with a Ligand with an IDD Structure (3-({[2-(carboxy…
6txp
monomer1-316
1×CIT; 1×4G7; 1×2WR; 1×NAP;
Assess
Human Aldose Reductase Mutant L300G in Complex with a Ligand with an IDD Structure ({5-fluoro-2-[(3…
8cnf
monomer1-316
1×NAP; 1×30L; 1×CIT;
Assess
Crystal structure of human AKR1B1 complexed with NADP+ and compound 41
5ouk
monomer1-316
1×NAP; 1×AVT;
Assess
Human Aldose Reductase complexed with Schl12221 ({2-[5-(3-NITROPHENYL)FURAN-2-YL]PHENYL}ACETIC ACID…
4prt
monomer1-316
1×NAP; 1×2WB;
Assess
Structure of Human Aldose Reductase Mutant A299G/L300A with a Citrate Molecule Bound in the Anion B…
8aqp
monomer1-316
1×NAP; 2×CIT; 1×PEG;
Assess
Crystal structure of human AKR1B1 complexed with NADP+ and compound 39
5ouj
monomer1-316
1×NAP; 1×AW8;
Assess
Human Aldose Reductase in Complex with a Ligand with a Fluoro-Indol-Acetic-Acid Structure (Schl4417…
8bjl
monomer1-316
1×NAP; 2×QXO; 1×DMS; 1×CIT; 1×PEG;
Assess
Human Aldose Reductase Mutant L300A in Complex with a Ligand with an IDD Structure ({5-fluoro-2-[(3…
6t3p
monomer1-316
1×NAP; 2×30L; 1×CIT;
Assess
Human Aldose Reductase Mutant L301A in Complex with a Ligand with an IDD Structure ({5-fluoro-2-[(3…
6td8
monomer1-316
1×30L; 1×CIT; 1×NAP;
Assess
Structure of Human Aldose Reductase Mutant A299G with a Citrate Molecule Bound in the Anion Binding…
8b34
monomer1-316
1×NAP; 2×CIT;
Assess
Human Aldose Reductase Mutant L300/301A in Complex with a Ligand with an IDD Structure ({5-fluoro-2…
6xum
monomer1-316
1×30L; 1×CIT; 1×NAP;
Assess
AKR1B1 at 0.75 MGy radiation dose.
6f81
monomer1-316
1×NAP; 2×CIT;
Assess
Human Aldose Reductase complexed with a ligand with an IDD structure ({5-fluoro-2-[(3-nitrobenzyl)c…
4qbx
monomer1-316
1×NAP; 1×30L; 1×CIT;
Assess
Aldose Reductase Mutant Leu 300 Pro complexed with Fidarestat
2agt
monomer1-316
1×CL; 1×NAP; 1×FID; 1×CIT;
Assess
Human aldose reductase in complex with NADP+ and the inhibitor IDD594. Investigation of global effe…
3ghr
monomer1-316
1×NDP; 1×LDT; 1×CIT;
Assess
Human aldose reductase in complex with NADP+ and the inhibitor IDD594. Investigation of global effe…
3ghs
monomer1-316
1×NDP; 1×LDT; 1×CIT;
Assess
The crystallographic structure of Aldose Reductase IDD393 complex confirms Leu300 as a specificity …
2pzn
monomer1-316
1×NAP; 1×393;
Assess
Crystal structure of human Aldose Reductase complexed with NADP+ and JF0048
4xzh
monomer1-316
1×NAP; 1×48I;
Assess
Human Aldose Reductase Mutant L301A in Complex with a Ligand with an IDD Structure (3-({[2-(carboxy…
6t7q
monomer1-316
1×4G7; 1×CIT; 1×NAP;
Assess
Human Aldose Reductase complexed with Schl12134 (3-[5-(3-nitrophenyl)-2-thienyl]propanoic acid) at …
4yu1
monomer1-316
1×NAP; 1×53N;
Assess
AKR1B1 at 1.65 MGy radiation dose.
6f82
monomer1-316
1×NAP; 2×CIT;
Assess
Human Aldose Reductase Mutant A299G/L300G in Complex with a Ligand with an IDD Structure (3-({[2-(c…
8b3n
monomer1-316
1×NAP; 1×4G7; 1×CIT;
Assess
Human aldose reductase in complex with NADP+ and the inhibitor lidorestat at 1.04 angstrom
1z3n
monomer1-316
1×NDP; 1×3NA;
Assess
Human Aldose Reductase complexed with a ligand with an IDD structure (2-[2-(1,3-benzothiazol-2-ylme…
4qr6
monomer1-316
1×NAP; 1×37V;
Assess
Crystal structure of human aldose reductase complexed with NADP and IDD552
1t41
monomer1-316
1×NAP; 1×ID5;
Assess
Human Aldose Reductase mutant T113V in complex with Zopolrestat
3m0i
monomer1-316
1×NAP; 1×ZST;
Assess
Human Aldose Reductase complexed with a ligand with an IDD structure (2) at 1.07 A.
4ys1
monomer1-316
1×NAP; 1×4G7;
Assess
AKR1B1 at 2.55 MGy radiation dose.
6f84
monomer1-316
1×NAP; 2×CIT;
Assess
Human aldose reductase in complex with NADP+ and the inhibitor IDD594. Investigation of global effe…
3ght
monomer1-316
1×NDP; 1×LDT; 1×CIT;
Assess
Crystal structure of human Aldose Reductase complexed with NADP and Minalrestat
1pwl
monomer1-316
1×BFI; 1×NAP;
Assess
Structure of Human Aldose Reductase Mutant L301A with a Citrate Molecule Bound in the Anion Binding…
6t27
monomer1-316
2×CIT; 1×NAP;
Assess
Human Aldose Reductase complexed with a ligand with an IDD structure (2-[5-fluoro-2-(prop-2-ynylcar…
4puw
monomer1-316
1×2WQ; 1×CIT; 1×NAP;
Assess
Human Aldose Reductase mutant T113V in complex with IDD393 crystallized in spacegroup P1
3mc5
monomer1-316
1×NAP; 1×393;
Assess
Human Aldose Reductase complexed with a ligand with an IDD structure (2-(2-carbamoyl-5-fluoro-pheno…
4puu
monomer1-316
1×NAP; 1×2WR;
Assess
Human Aldose Reductase in complex with ALR43
6tuf
monomer1-316
1×CIT; 1×NAP; 1×NXQ;
Assess
Human aldose reductase in complex with NADP+ and the inhibitor IDD594. Investigation of global effe…
3ghu
monomer1-316
1×NDP; 1×LDT; 1×CIT;
Assess
Human Aldose Reductase complexed with a ligand with a new scaffold at 1.26 A
4qx4
monomer1-316
1×NAP; 2×3E2;
Assess
Structure of Human Aldose Reductase Mutant L300A with a Citrate Molecule Bound in the Anion Binding…
6t5g
monomer1-316
2×CIT; 1×NAP;
Assess
Human aldose reductase in complex with a nitrile-containing IDD inhibitor
3t42
monomer1-316
1×NAP; 1×3T4; 1×CIT;
Assess
Human aldose reductase mutant T113V complexed with IDD393
3m64
monomer1-316
1×NAP; 1×393;
Assess
Crystal structure of Aldose Reductase complexed with 2S4R (Stereoisomer of Fidarestat, 2S4S)
1x98
monomer1-316
1×NAP; 1×CIT; 1×FIS;
Assess
Crystal structure of Aldose Reductase with citrates bound in the active site
1x96
monomer1-316
1×NAP; 2×CIT;
Assess
Crystal structure of Aldose Reductase complexed with 2R4S (Stereoisomer of Fidarestat, 2S4S)
1x97
monomer1-316
1×NAP; 1×FIR;
Assess
Human Aldose Reductase complexed with novel Sulfonyl-pyridazinone Inhibitor
1z89
monomer1-316
1×NAP; 1×62P;
Assess
Aldose reductase complexed with nitrophenyl-oxadiazol type inhibitor at 1.43 A
2ikg
monomer1-316
1×NAP; 1×BTO;
Assess
Human Aldose Reductase complexed with four tolrestat molecules at 1.5 A resolution.
2fzb
monomer1-316
1×NAP; 4×TOL;
Assess
Human Aldose Reductase C298S mutant in Complex with NADP+ in Space Group P212121
3q67
monomer1-316
1×NAP; 4×SO4;
Assess
Human Aldose Reductase in Complex with NADP+ and WY14643 in Space Group P212121
5ha7
monomer1-316
1×NAP; 1×WY1; 4×SO4;
Assess
Structure of Human Aldose Reductase Mutant L300/301A with a Citrate Molecule Bound in the Anion Bin…
6y03
monomer1-316
1×CIT; 1×NAP;
Assess
Novel Benzothiazepine Inhibitor in Complex with human Aldose Reductase
3p2v
monomer1-316
1×NAP; 2×DOY;
Assess
HUMAN ALDOSE REDUCTASE COMPLEXED WITH IDD384 INHIBITOR
1el3
monomer1-316
1×NAP; 1×I84;
Assess
Crystal Structure of Human Aldose Reductase Complexed with Tolmetin
3s3g
monomer1-316
1×NAP; 1×TLT;
Assess
Crystal structure of human aldose reductase complexed with NADP and IDD552 at ph 5
1t40
monomer1-316
1×NAP; 1×ID5;
Assess
Human aldose reductase complexed with IDD 740 inhibitor
3g5e
monomer1-316
1×NDP; 1×Q74;
Assess
Crystal Structure of Human Aldose Reductase Complexed with Sulindac Sulfone
3rx2
monomer1-316
1×NAP; 1×SLO;
Assess
Crystal Structure of Human Aldose Reductase Complexed with Sulindac
3rx3
monomer1-316
1×NAP; 1×SUZ;
Assess
Aldose reductase complexed with a nitro compound
3v35
monomer1-316
1×NAP; 1×NTI; 23×DMF;
Assess
Crystal Structure Of Aldose Reductase (AKR1B1) Complexed With NADP+ And Epalrestat
4jir
monomer1-316
1×EPR; 2×SO4; 1×NAP;
Assess
Crystal Structure of Human Aldose Reductase complexed with Sulindac Sulfide
3rx4
monomer1-316
1×NAP; 1×SFI;
Assess
Aldose reductase complexed with glceraldehyde
3v36
monomer1-316
1×NAP; 1×3GR; 1×0PY;
Assess
Human Aldose Reductase in Complex with NADP+ in Space Group P212121
3q65
monomer1-316
1×NAP; 5×SO4; 1×GOL;
Assess
Crystal structure of human Aldose Reductase complexed with NADP+ and JF0049
4xzi
monomer1-316
1×NAP; 1×F49;
Assess
Human Aldose Reductase structure
2r24
monomer1-316
1×NAP; 1×LDT;
Assess
Complex of Aldose Reductase with inhibitor IDD 1219
4gca
monomer2-316
1×NAP; 1×2X9;
Assess
Human Aldose Reductase complexed with novel Sulfonyl-pyridazinone Inhibitor
1z8a
monomer2-316
1×NAP; 1×62P;
Assess
Aldose reductase in complex with NSAID-type inhibitor at 1.0 A resolution
3u2c
monomer2-316
1×NAP; 2×PEG; 2×PG5; 1×CIT; 1×SUZ; 1×PG4;
Assess
Human Aldose Reductase complexed with Schl7815 ((3-[3-(5-NITROFURAN-2-YL)PHENYL]PROPANOIC ACID)at 1…
4prr
monomer2-316
1×NAP; 1×2W9;
Assess
Human Aldose Reductase complexed with Schl7802 at 1.06 A
4pr4
monomer2-316
1×NAP; 1×2W8;
Assess
Human aldose reductase mutant T113C complexed with IDD594
3lbo
monomer2-316
1×NAP; 1×LDT; 1×CIT; 1×BR;
Assess
Human Aldose Reductase complexed with a ligand with an IDD structure ([2-(benzylcarbamoyl)-5-fluoro…
4q7b
monomer2-316
1×NAP; 1×2YZ;
Assess
Human aldose reductase mutant L300P complexed with uracil-type inhibitor at 1.45 A.
2pdh
monomer2-316
1×NAP; 1×47D;
Assess
Aldose Reductase in complex with novel biarylic inhibitor
3dn5
monomer2-316
1×NAP; 1×53N;
Assess
Crystal Structure Of Aldose Reductase (AKR1B1) Complexed With NADP+ And AT-003
8fh7
monomer2-316
1×NAP; 1×XY0; 3×EDO;
Assess
Human aldose reductase mutant L301M complexed with tolrestat.
2pdl
monomer2-316
1×NAP; 1×TOL;
Assess
Human Aldose reductase complexed with inhibitor zopolrestat at 1.48 A(1 day soaking).
2fz8
monomer2-316
1×NAP; 1×ZST;
Assess
Human aldose reductase complexed with nitrofuryl-oxadiazol inhibitor at 1.55 A
2ikh
monomer2-316
1×NAP; 1×LIT;
Assess
Human aldose reductase mutant V47I complexed with fidarestat.
2pd9
monomer2-316
1×NAP; 1×FID;
Assess
Human aldose reductase mutant L301M complexed with sorbinil.
2pdk
monomer2-316
1×NAP; 1×SBI;
Assess
Human aldose reductase mutant L300A complexed with zopolrestat at 1.55 A.
2pdi
monomer2-316
1×NAP; 1×ZST;
Assess
Human aldose reductase complexed with nitro-substituted IDD-type inhibitor
2ikj
monomer2-316
1×NAP; 1×393;
Assess
Human Aldose Reductase complexed with novel naphtho[1,2-d]isothiazole acetic acid derivative (2)
2nvd
monomer2-316
1×NAP; 3×ITB;
Assess
Human aldose reductase mutant C303D complexed with fidarestat.
2pdw
monomer2-316
1×NAP; 1×FID;
Assess
Human aldose reductase mutant C303D complexed with IDD393.
2pdu
monomer2-316
1×NAP; 1×393;
Assess
Human aldose reductase mutant L300A complexed with IDD393.
2pdj
monomer2-316
1×NAP; 1×393;
Assess
Human Aldose Reductase-zopolrestat complex obtained by cocrystallisation after one day (1day_cocrys…
2hvn
monomer2-316
1×NAP; 1×ZST;
Assess
Crystal structure of human Aldose Reductase complexed with zopolrestat after 3 days soaking (3days_…
2dux
monomer2-316
1×NAP; 1×ZST;
Assess
Human Aldose Reductase complexed with inhibitor zopolrestat after 3 days soaking (3days_soaked_2)
2duz
monomer2-316
1×NAP; 1×ZST;
Assess
Human aldose reductase mutant V47I complexed with zopolrestat
2pd5
monomer2-316
1×NAP; 1×ZST;
Assess
Human aldose reductase mutant F121P complexed with zopolrestat.
2pdb
monomer2-316
1×NAP; 1×ZST;
Assess
Human Aldose Reductase complexed with inhibitor zopolrestat after six days soaking.
2fz9
monomer2-316
1×NAP; 1×ZST;
Assess
Crystal Structure Of Aldose Reductase (AKR1B1) Complexed With NADP+ And AT-003 Soaked In Hydrogen P…
8fh8
monomer2-316
1×NAP; 1×XY0; 4×EDO; 13×PEO;
Assess
Crystal Structure Of Aldose Reductase (AKR1B1) Complexed With NADP+ And AT-001
8fh5
monomer2-316
1×NAP; 1×XXQ;
Assess
Human aldose reductase mutant S302R complexed with IDD 393.
2pdp
monomer2-316
1×NAP; 1×393;
Assess
AN UNLIKELY SUGAR SUBSTRATE SITE IN THE 1.65 ANGSTROMS STRUCTURE OF THE HUMAN ALDOSE REDUCTASE HOLO…
1ads
monomer2-316
1×NAP;
Assess
Human Aldose Reductase complexed with novel naphtho[1,2-d]isothiazole acetic acid derivative (3)
2nvc
monomer2-316
1×NAP; 1×ITA;
Assess
Human aldose reductase mutant F121P complexed with IDD393.
2pdc
monomer2-316
1×NAP; 1×393;
Assess
Human aldose reductase double mutant S302R-C303D complexed with fidarestat.
2pdy
monomer2-316
1×NAP; 1×FID;
Assess
Human Aldose Reductase-zopolrestat complex obtained by cocrystallisation (10days_cocryst)
2hvo
monomer2-316
1×NAP; 1×ZST;
Assess
Crystal Structure Of Aldose Reductase (AKR1B1) Complexed With NADP+ And AT-007
8fh9
monomer2-316
1×NAP; 1×XYK; 5×EDO;
Assess
Human aldose reductase mutant S302R complexed with uracil-type inhibitor.
2pdn
monomer2-316
1×NAP; 1×47D;
Assess
Crystal Structure of Aldose Reductase complexed with Dichlorophenylacetic acid
2is7
monomer2-316
1×NAP; 1×2CL;
Assess
Human aldose reductase mutant C303D complexed with uracil-type inhibitor.
2pdq
monomer2-316
1×NAP; 1×47D;
Assess
Human aldose reductase mutant S302R complexed with zopolrestat.
2pdm
monomer2-316
1×NAP; 1×ZST;
Assess
AN ANION BINDING SITE IN HUMAN ALDOSE REDUCTASE: MECHANISTIC IMPLICATIONS FOR THE BINDING OF CITRAT…
2acq
monomer2-316
1×G6P; 1×NAP;
Assess
TYROSINE-48 IS THE PROTON DONOR AND HISTIDINE-110 DIRECTS SUBSTRATE STEREOCHEMICAL SELECTIVITY IN T…
2acu
monomer2-316
1×NAP; 1×CIT;
Assess
AN ANION BINDING SITE IN HUMAN ALDOSE REDUCTASE: MECHANISTIC IMPLICATIONS FOR THE BINDING OF CITRAT…
2acr
monomer2-316
1×CAC; 1×NAP;
Assess
REFINED 1.8 ANGSTROMS STRUCTURE OF HUMAN ALDOSE REDUCTASE COMPLEXED WITH THE POTENT INHIBITOR ZOPOL…
1mar
monomer2-316
1×NAP; 1×ZST;
Assess
Aldose reductase tertiary complex with NADPH and DEG
2f2k
monomer2-316
1×NDP; 1×TGG;
Assess
Crystal Structure of Aldose Reductase complexed with 2-Hydroxyphenylacetic Acid
2inz
monomer2-316
1×NAP; 1×OHP;
Assess
Crystal Structure Of Aldose Reductase (AKR1B1) Complexed With NADP+ And Two AT-001
8fh6
monomer2-316
1×NAP; 2×XXQ; 3×EDO;
Assess
Crystal Structure of Aldose Reductase complexed with Lipoic Acid
2iqd
monomer2-316
1×NAP; 1×LPA;
Assess
Apo R268A human aldose reductase
1xgd
monomer2-316
Assess
CRYSTAL STRUCTURE OF HUMAN ALDOSE REDUCTASE COMPLEXED WITH THE INHIBITOR ZENARESTAT.
1iei
monomer2-316
1×NAP; 1×ZES;
Assess
Human Aldose Reductase in complex with NADP+ and the inhibitor IDD594 at 0.66 Angstrom
1us0
monomer1-314
1×NDP; 1×LDT; 2×CIT;
Assess
Human aldose reductase in complex with NADP+ and the inhibitor IDD594 at temperature of 15K
2i16
monomer1-314
1×NDP; 1×LDT; 2×CIT;
Assess
Human aldose reductase in complex with NADP+ and the inhibitor IDD594 at temperature of 60K
2i17
monomer1-314
1×NDP; 1×LDT; 2×CIT;
Assess
Complex of Aldose Reductase with NADP+ and simaltaneously bound competetive inhibitors Fidarestat a…
2pfh
monomer1-314
1×CL; 1×NDP; 1×LDT; 1×FID; 2×CIT;
Assess
Crystal structure of human AR complexed with NADP+ and AK198
4qxi
monomer1-314
1×NAP; 1×I98;
Assess
Human Aldose Reductase mutant T113C in complex with IDD388
3lep
monomer1-314
1×NAP; 1×388; 1×BR; 1×CIT;
Assess
Human Aldose Reductase complexed with Schl7764 at 1.12 A
4nkc
monomer3-316
1×2HZ; 1×NAP;
Assess
AKR1B1 at 3.45 MGy radiation dose.
6f8o
monomer1-314
1×NAP; 1×CIT;
Assess
Human Aldose Reductase complexed with a ligand with an IDD structure at 1.20 A (1)
4rpq
monomer3-316
1×3UH; 1×NAP;
Assess
Human Aldose Reductase mutant T113S complexed with Zopolrestat
3len
monomer3-316
1×NAP; 1×ZST;
Assess
Human aldose reductase with uracil-type inhibitor at 1.42A.
2pdg
monomer3-316
1×NAP; 1×47D;
Assess
Human aldose reductase mutant L300P complexed with zopolrestat.
2pdf
monomer3-316
1×NAP; 1×ZST;
Assess
Human Aldose Reductase complexed with inhibitor zopolrestat after three days soaking (3days_soaked_…
2hv5
monomer3-316
1×NAP; 1×ZST;
Assess
Human Aldose Reductase complexed with zopolrestat after 6 days soaking(6days_soaked_2)
2dv0
monomer3-316
1×NAP; 1×ZST;
Assess
Human Aldose Reductase mutant T113A complexed with Zopolrestat
3mb9
monomer3-316
1×NAP; 1×ZST;
Assess
AN ANION BINDING SITE IN HUMAN ALDOSE REDUCTASE: MECHANISTIC IMPLICATIONS FOR THE BINDING OF CITRAT…
2acs
monomer3-316
1×NAP; 1×CIT;
Assess
ALRESTATIN BOUND TO C298A/W219Y MUTANT HUMAN ALDOSE REDUCTASE
1az1
monomer3-316
1×NAP; 2×ALR;
Assess
Crystal Structure of Aldose Reductase complexed with Phenylacetic Acid
2ine
monomer3-316
1×NAP; 1×PAC;
Assess
Crystal Structure of Aldose Reductase complexed with Hexanoic Acid
2iq0
monomer3-316
1×NAP; 1×6NA;
Assess
Crystal Structure of C298A W219Y Aldose Reductase complexed with Phenylacetic Acid
2isf
monomer3-316
1×NAP; 1×PAC;
Assess
Crystal Structure of C298A W219Y Aldose Reductase complexed with Dichlorophenylacetic acid
2ipw
monomer3-316
1×NAP; 1×2CL;
Assess
THE CRYSTAL STRUCTURE OF THE ALDOSE REDUCTASE NADPH BINARY COMPLEX
1abn
monomer3-316
1×NDP;
Assess
CITRATE BOUND, C298A/W219Y MUTANT HUMAN ALDOSE REDUCTASE
1az2
monomer3-316
1×NAP; 1×CIT;
Assess
Perdeuterated alr2 in complex with idd594
2qxw
monomer1-313
1×NDP; 1×LDT; 2×CIT;
Assess
Structure of Human Aldose Reductase Mutant A299G/L300G with a Citrate Molecule Bound in the Anion B…
8aqg
monomer1-313
1×NAP; 2×CIT;
Assess
Human aldose reductase mutant T113V complexed with IDD594
3lz5
monomer1-313
1×NAP; 1×LDT; 1×CIT;
Assess
Human Aldose Reductase Mutant A299G/L300G in Complex with a Ligand with an IDD Structure ({5-fluoro…
8b3r
monomer1-313
1×NAP; 1×30L; 2×CIT;
Assess
Human aldose reductase mutant T113S complexed with IDD388
3lz3
monomer1-313
1×NAP; 1×388; 1×BR; 1×CIT;
Assess
Human Aldose Reductase in complex with ALR25
6tuc
monomer1-313
1×CIT; 1×NXK; 1×NAP;
Assess
Bond breakage and relocation of a covalently bound bromine of IDD594 in a complex with hAR T113A mu…
3onc
monomer2-314
1×NAP; 1×LDT; 1×BR; 1×CIT;
Assess
Human aldose reductase complexed with tolrestat at 1.08 A resolution.
2fzd
monomer1-313
1×NAP; 1×TOL;
Assess
Human Aldose Reductase mutant T113A complexed with IDD 594
3lql
monomer1-313
1×NAP; 1×LDT; 1×CIT; 1×BR;
Assess
Bond breakage and relocation of a covalently bound bromine of IDD594 in a complex with hAR T113A mu…
3onb
monomer2-313
1×NAP; 1×LDT; 1×BR; 1×CIT;
Assess
Human aldose reductase double mutant S302R-C303D complexed with zopolrestat.
2pdx
monomer2-313
1×NAP; 1×ZST;
Assess
Human aldose reductase mutant T113S complexed with IDD594
3ld5
monomer3-313
1×NAP; 1×LDT; 1×CIT; 1×BR;
Assess
Human aldose reductase mutant T113A complexed with IDD388
3lqg
monomer3-313
1×NAP; 1×388; 1×BR;
Assess
Human aldose reductase complexed with halogenated IDD-type inhibitor
2iki
monomer2-312
1×NAP; 1×388;
Assess

1 SWISS-MODEL model

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
1x96.1.Amonomer0.891-316
1×NAP;99.68
Assess